Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin gamma1 Fc or CH3 region.
about
Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody.A recombinant bispecific single-chain Fv antibody against HLA class II and FcgammaRIII (CD16) triggers effective lysis of lymphoma cells.Application of the Fc fusion format to generate tag-free bi-specific diabodies.Stability engineering of scFvs for the development of bispecific and multivalent antibodies.Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer.Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv): the case of the hEx3 diabody.Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domainRecombinant bispecific antibodies for cancer therapy.Recombinant approaches to IgG-like bispecific antibodies.Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.Self-assembly of antibodies by chemical inductionResearch and development of next generation of antibody-based therapeuticsShark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development.A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity.The making of bispecific antibodiesThe effect of an agglutogen on virus infection: biotinylated filamentous phages and avidin as a model.Bispecific antibodies: design, therapy, perspectives.A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A.
P2860
Q31016741-45D714F5-2BB1-47D4-ADDE-6FB171CD999DQ33200753-D382D2EE-E99B-4F94-8B48-F8F1C4658C42Q33518858-2BAFE2AD-A8B1-416C-BC95-94246843FC00Q33574335-A93F668E-850B-47CB-BF43-B89667386E35Q34116897-F91F441E-E30D-4F9D-AFDC-CA28F58FDE2FQ34503084-2CF143A7-947C-4ABB-AFF0-2AB5237F2E12Q34724092-A2CCAAB9-8816-4C58-897F-C0CFAE13EC6BQ36013830-EEBCCD8C-2313-4302-ACD2-468A5330EF51Q36139512-D0AF8D3A-4778-42DE-91C0-1903DFADD674Q36445879-B4F5664F-62A4-4051-AC21-3E80B01ADB4CQ36611798-95194774-4490-4909-BA4E-1A37622E0AD2Q37778732-B02F0E18-2885-4D99-AC2B-EF749A522591Q38236706-14BEAFBE-36BA-422B-928B-B8981E9F204FQ40448458-FC57A3D6-BE7A-4633-8C28-CF8FBD00FEDBQ42323236-B58CBDFF-1D2A-42AB-8A52-60503E5379B3Q44014765-B34C2C47-8968-4C4D-8341-68C6D128644AQ49195146-A169F681-F507-41CF-9C07-2D7BD7B469A9Q49805666-CBA12699-C162-4719-8E2C-FC95D8BD52A2
P2860
Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin gamma1 Fc or CH3 region.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Novel tetravalent and bispecif ...... bulin gamma1 Fc or CH3 region.
@en
type
label
Novel tetravalent and bispecif ...... bulin gamma1 Fc or CH3 region.
@en
prefLabel
Novel tetravalent and bispecif ...... bulin gamma1 Fc or CH3 region.
@en
P2093
P2860
P1433
P1476
Novel tetravalent and bispecif ...... bulin gamma1 Fc or CH3 region.
@en
P2093
P2860
P356
10.1016/S0014-5793(99)00782-6
P407
P577
1999-07-01T00:00:00Z